Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA THERAPEUTICS CORP - ENTERED INTO A SALES AGREEMENT WITH SVB LEERINK
* MEDICENNA THERAPEUTICS - PURSUANT TO AGREEMENT MAY SELL, THROUGH AT-THE-MARKET OFFERINGS, COMMON SHARES HAVING OFFERING PRICE OF UP TO US$25 MILLION